More on Cardinal Health fiscal Q3 results


Revenues: $21.4B (-13%), Pharmaceutical segment: $18.8B (-15%), Medical segment: $2.7B (+7%).

Operating earnings: $508M (+6.9%).

EPS: $0.91 (-9%).

(CAH)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs